Lee, et al., 1998, Eur. J. Immunol., 28:2726-2737.* |
Johannes, et al., 1997, J. Biol. Chem., 272:19554-61.* |
Johannes, et al., 1996, Molec Biol of the Cell 7(Supp):75a.* |
Allinquant, B et al. “Downregulation of Amyloid Precursor Protein Inhibits Neurite Outgrowth In Vitro,” J. Cell Biol. 128(5):919-27 (1995). |
Boël, Pascale, et al. “BAGE: a New Gene Encoding an Antigen Recognized on Human Melanomas by Cytolytic T Lymphocytes,” Immunite 2:167-75 (1995). |
Bower, Stanley et al. “Cloning and Characterization of the Bacillus subtilis birA Gene Encoding a Repressor of the Biotin Operon,” J. Bacteriology 177(9):2572-75 (1995). |
Brichard, Vincent et al. “The Tyrosinase Gene Codes for an Antigen Recognized by Autologous Cytolytic T Lymphocytes on HLA-A2 Melanomas,” J. Exp. Med. 178:489-95 (1993). |
Calderwood, Stephen B. et al. “Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli,” Proc. Natl. Acad. Sci. USA 84(13):4364-68 (1987). |
Chicz, Roman M. et al. “Analysis of MHC-presented peptides: applications in autoimmunity and vaccine development,” Immunol. Today 15(4):155-60 (1994). |
Ciernik, I. Frank et al. “Mutant Oncopeptide Immunization Induced CTL Specifically Lysing Tumor Cells Endogenously Expressing the Corresponding Intact Mutant p53,” Hybridoma 14(2):139-42 (1995). |
Coulie, Pierre G. et al. “A New Gene Coding for a Differentiation Antigen Recognized by Autologous Cytolytic T Lymphocytes on HLA-A2 Melanomas,” J. Exp. Med. 180:35-42 (1994). |
Davis, Heather L. et al. “DNA-Mediated Immunization in Mice Induces a Potent MHC Class I-Restricted Cytotoxic T Lymphocyte Response to the Hepatitis B Envelope Protein,” Hum. Gene Therapy 6:1447-56 (1995). |
De Plaen, Etienne et al. “Structure, chromosomal localization, and expression of 12 genes of the MAGE family,” Immunogenetics 40:360-69 (1994). |
Feltkamp, Mariet C. W. et al. “Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells,” Eur. J. Immunol. 23:2242-49 (1993). |
Furukawa, Keiko et al. “Clonal Expansion of CD8+ Cytotoxic T Lymphocytes against Human T Cell Lymphotrophic Virus Type I (HTLV-I) Genome Products in HTLV-I-associated Myelopathy/Tropical Spastic Paraparesis Patients,” J. Clin. Invest. 94:1830-39 (1994). |
Gnjatic, Sacha et al. “Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules,” Eur. J. Immunol. 25:1638-42 (1995). |
Johannes, Ludger et al. “Retrograde Transport of KDEL-bearing B-fragment of Shiga Toxin,” J. of Biological Chemistry 272(31):19554-19561 (1997). |
Johannes, L. and Goud, B., “Shiga toxin as a tool to study retrograde transport,” Molecular Biology of the Cell 7(Supp.):75a (1996) (Annual Meeting of the 6th International Congress of Cell Biology and the 36th American Society for Cell Biology, San Francisco, California). |
Kawakami, Yutaka et al. “Identification of the Immunodominant Peptides of the MART-1 Human Melanoma Antigen Recognized by the Majority of HLA-A2-restricted Tumor Infiltrating Lymphocytes,” J. Exp. Med. 180:347-52 (1994). |
Kim, Jae Hong et al. “Dynamic Measurement of the pH of the Golgi Complex in Living Cells Using Retrograde Transport of the Verotoxin Receptor,” J. Cell Biol. 134(6):1387-99 (1996). |
Lamb, “Nucleotide sequence of cloned cDN coding for preproricin,” Eur. J. of Biochem. 148(2):265-70 (1995). |
Lewis, Michael L. and Pelham, Hugh R. B. “A human homologue of the yeast HDEL receptor,” Nature 348:162-63 (1990). |
Lewis, Michael J. and Pelham, Hugh R. B. “Ligand-Induced Redistribution of a Human KDEL Receptor from the Golgi Complex to the Endoplasmic Reticulum,” Cell 68:353-64 (1992). |
Lingwood, Clifford A. “erotoxins and Their Glycolipid Recetpros,” Adv. Lipid Res. 25:189-211 (1993). |
Murray, R. J. et al. “Identification of Target Antigens for the Human Cytotoxic T Cell Response to Epstein-Barr Virus (EBV): Implications for the Immune Control of EBV-positive Malignancies,” J. Exp. Med. 176:157-68 (1992). |
O'Brien, A. D. et al. “Shiga Toxin: Biochemistry, Genetics, Mode of Action, and Role in Pathogenesis,” Curr. Top. Microbiol. Immunol. 180:65-94 (1992). |
Peace, David J. et al. “Induction of T Cells Specific for the Mutated Segment of Oncogenic P21-rasprotein by Immunization In Vivo with the Oncogenic Protein,” J. Immunotherapy 14(2):110-14 (1993). |
Pelham, Hugh R. B. et al. “Toxin entry: how reversible is the secretory pathway?” Trends Cell Biol. 2:183-85 (1992). |
Rapak, Andrzej et al. “Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to the cytosol,” Proc. Natl. Acad. Sci. USA 94:3783-3788 (1997). |
Rehermann, Barbara et al. “The Cytotoxic T Lymphocyte Response to Multiple Hepatitis B Virus Polymerase Epitopes During and After Acute Viral Hepatitis,” J. Exp. Med. 181:1047-58 (1995). |
Sandvig, Kirsten et al. “Retrograde Transport from the Golgi complex to the ER of Both Shiga Toxin and the Nontoxic Shiga B-gragment Is Regulated by Butryric Acid and cAMP,” J. Cell. Biol. 126(1):53-64 (1994). |
Sandvig, Kirsten et al. “Retrograde transport of endocytosed Shiga toxin to the endolasmic reticulum,” Nature 358:510-12 (1992). |
Seidah, Nabil G. et al. “Complete Amino Acid Sequence of Shigella Toxin B-chain,” J. Biol. Chem. 261(30):13928-31 (1986). |
Strockbine, Nancy A. et al. “Cloning and Sequencing of the Genes for Shiga Toxin from Shigella dysenteriae Type 1,” J. Bacteriology 170(3):1116-22 (1988). |
Suk, Guo-Fu et al. “Construction of Stable LamB-Shiga Toxin B Subunit Hybrids: Analysis of Expression in Salmonella typhimurium aroA Strains and Stimulation of B Subunit-Specific Mucosal and Serum Antibody Responses,” Infection and Immunity 60:3345-59 (1992). |
Traversari, Catia et al. “A Nonapeptide Encoded by Human Gene MAGE-1 Is Recognized on HLA-A1 by Cytolytic T Lymphocytes Directed against Tumor Antigen MZ2-E,” J. Exp. Med. 176:1453-57 (1992). |
Tsao, Kwei-Lan et al. “A Versatile plasmid expression vector for the production of biotinylated proteins by site-specific, enzymatic modification in Escherichia coli,” Gene 169:59-64 (1996). |
Van den Eynde, Beno{haeck over (i)}t et al. “A New Family of Genes Coding for an Antigen Recognized by Autologous Cytoloic T Lymphocutes on a Human Melanoma,” J. Exp. Med. 182:689-98 (1995). |